Welcome to our dedicated page for Clearsign Technologies SEC filings (Ticker: CLIR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking ClearSign Technologies Corporation’s path from breakthrough ultra-low NOx burners to full-scale commercialization shouldn’t mean wading through dense engineering prose. Yet every ClearSign quarterly earnings report 10-Q filing hides critical details—cash runway, grant receipts, hydrogen-capable burner pilots—inside pages of combustion diagrams. Stock Titan’s AI extracts the essentials so you can focus on decisions, not document mining.
Our platform automatically tags every disclosure type the moment it hits EDGAR. Need ClearSign insider trading Form 4 transactions or ClearSign Form 4 insider transactions real-time? They’re surfaced with one-click charts. Wonder what changed in the ClearSign annual report 10-K simplified? AI highlights new risk factors and revenue milestones. We even decode each ClearSign 8-K material events explained, from OEM partnership wins to equity raises, in plain English.
Here’s what you’ll find:
- AI-powered summaries that make ClearSign SEC filings explained simply, including footnote trends and R&D spend.
- Real-time alerts for ClearSign executive stock transactions Form 4—spot buying or selling before the market reacts.
- Side-by-side comparisons that turn any ClearSign earnings report filing analysis into a five-minute read.
- Proxy insights: dig into ClearSign proxy statement executive compensation without paging through tables.
- Context cards for liquidity, hydrogen burner adoption rates, and regulatory compliance so understanding ClearSign SEC documents with AI becomes second nature.
Whether you monitor grant funding, track commercialization timelines, or gauge sentiment through insider trades, Stock Titan delivers the complete picture—updated in seconds and written for humans. No more searching; the answers to “Where can I find ClearSign’s quarterly earnings report 10-Q filing?” or “How do I read ClearSign’s 10-K risk factors?” are already waiting right here.
On July 1, 2025, ClearSign Technologies Corp. (CLIR) director David M. Maley received 9,452 restricted stock units (RSUs) under the company’s 2021 Equity Incentive Plan as prorated compensation for board service through July 25, 2025, which is noted as his final day as a non-executive director. Each RSU converts into one share of common stock (or cash equivalent) upon the earliest of a change-in-control, disability, death, or separation from service. Following this grant, Maley beneficially owns 105,443 derivative securities linked to CLIR common stock. The award was recorded at a transaction price of $0.00 and was reported as direct ownership on Form 4 filed July 3, 2025.
ClearSign Technologies (CLIR) – Form 4 insider filing: Director Gill Todd Silva was granted 32,638 restricted stock units (RSUs) on 07/01/2025 as non-executive board compensation under the 2021 Equity Incentive Plan. Each RSU entitles the holder to one common share (or cash equivalent) at a cost of $0, increasing Silva’s derivative holdings to 93,639 RSUs. The award contains contingent vesting; the units vest only upon the earliest of a change in control, disability, death, or separation from service. No shares were sold or otherwise disposed of, so the director’s beneficial ownership rose while the company incurred no immediate cash expense.
ClearSign Technologies Corp. (CLIR) – Form 4 filing dated 07/03/2025
Non-executive director Catharine de Lacy received 32,175 Restricted Stock Units (RSUs) on 07/01/2025 under the company’s 2021 Equity Incentive Plan as quarterly board compensation. Each RSU entitles the holder to one share of common stock (or cash equivalent) at vesting. Following the award, the director now beneficially owns 218,957 derivative securities tied to CLIR common stock and retains direct ownership (no indirect ownership reported).
The RSUs vest upon the earliest of: (1) a change in control, (2) the director’s disability, (3) death, or (4) separation from service. No open-market purchase or sale occurred; the transaction code “A” denotes an award.
For investors, this filing signals routine equity-based compensation designed to align director interests with shareholder value. It does not reflect cash outflows by the company nor insider buying pressure in the open market.
ClearSign Technologies Corp. (CLIR) Form 4 filing shows that non-executive director Judith S. Schrecker received 46,296 Restricted Stock Units (RSUs) on 01 July 2025 as quarterly board compensation under the 2021 Equity Incentive Plan.
The RSUs carry an exercise price of $0.00 and will vest upon the earliest of: (1) a Change in Control; (2) the director’s disability; (3) death; or (4) separation from service. Each RSU converts into one share of common stock or its cash equivalent.
Following the grant, Schrecker’s total derivative holdings increased to 431,957 RSUs. No common shares were sold or otherwise disposed of, and the transaction was filed individually by the reporting person.
Because the award represents routine board compensation without immediate vesting or open-market activity, the market impact is expected to be limited, though it modestly enhances insider equity alignment.
ClearSign Technologies Corporation (CLIR) – Form 4 insider filing
On 1 July 2025, non-executive director Louis J. Basenese received an equity award of 34,722 Restricted Stock Units (RSUs) under the company’s 2021 Equity Incentive Plan. Each RSU entitles the holder to one share of common stock (or its cash equivalent) at no cost.
Vesting terms: the RSUs vest on the earliest of (1) a Change in Control, (2) the director’s disability, (3) the director’s death, or (4) the director’s separation from service. Until one of these events occurs, the units remain unvested and non-transferable.
Post-transaction holdings: Following the grant, Mr. Basenese beneficially owns 45,645 derivative securities (RSUs) in a direct capacity. No open-market purchases or sales of common stock were reported, and no cash consideration was exchanged.
Key takeaways for investors:
- The award is routine quarterly board compensation and signals continued alignment of the director’s interests with shareholder value.
- Because RSUs convert on a one-for-one basis, potential dilution is limited to 34,722 shares, an amount that is typically immaterial relative to total shares outstanding (exact share count not provided in the filing).
- No information on company performance, financial results, or additional insider transactions is included in this document.
FAQ
What is the current stock price of Clearsign Technologies (CLIR)?
What is the market cap of Clearsign Technologies (CLIR)?
What does ClearSign Technologies Corp specialize in?
What industries does ClearSign serve?
What are ClearSign's key technologies?
How does ClearSign support decarbonization?
What makes ClearSign's solutions unique?
Who are ClearSign's strategic partners?
What is ClearSign Eye™ technology?
What is ClearSign Core™ technology?
How does ClearSign address emissions regulations?
What is ClearSign's role in the hydrogen economy?
